ESMO Breast Cancer 2026 Highlights: Pumitamig + DB-1305/BNT325

• June 26, 2026

Identification of potential vinorelbine-associated prognostic genes in breast cancer through integrative bioinformatics and experimental validation

• by Yi Wu, Guimei Yang, Yixian Li, Yunjing Ruan, Qianmei Yang

• June 26, 2026

ESMO Breast Cancer 2026 Highlights: TRAK-ER

Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.

• June 26, 2026

• 1 min

Clinical and prognostic implications of pituitary tumor-transforming gene 1 in solid tumors

• by Peng Dong, Weiguang Zhou, Longhui Xiong, Zhijian Li, Zhanqiao Zhang, Jianyang Yang, Huan Cao

• June 26, 2026